The antagonist activity of short-chain toxins from snake venoms toward the nicotinic acetylcholine receptor (nAChR) is neutralized upon binding to a toxin-specific monoclonal antibody called M␣2-3 (1). To establish the molecular basis of this specificity, we predicted from both mutational analyses and docking procedures the structure of the M␣2-3-toxin complex. From knowledge of the functional paratope and epitope, and using a double-mutation cycle procedure, we gathered evidence that Asp 31 in complementarity determining region 1H is close to, and perhaps interacts with, Arg 33 in the antigen. The use of this pair of proximate residues during the selection procedure yielded three models based on docking calculations. The selected models predicted the proximity of Tyr 49 and/or Tyr 50 in the antibody to Lys 47 in the toxin. This was experimentally confirmed using another round of double-mutation cycles. The two models finally selected were submitted to energy minimization in a CHARMM22 force field, and were characterized by a root mean square deviation of 7.0 ؎ 2.9 Å. Both models display most features of antibody-antigen structures. Since M␣2-3 also partially mimics some binding properties of nAChR, these structural features not only explain its fine specificity of recognition, but may also further clarify how toxins bind to nAChR.
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It is of particular interest in the case of toxic antigens to understand the structural characteristics and molecular events underlying the binding properties of neutralizing antibodies. M␣2-3 is a murine monoclonal antibody (IgG2a/ isotype), which binds with high affinity to potent antagonists of the nicotinic acetylcholine receptor (nAChR) 1 (1) . Curaremimetic short-chain toxins from Elapidae and Hydrophiidae snake venoms form a family of small proteins comprising 60 -62 amino acid residues and 4 disulfides. They bind to nAChR with high affinities, their apparent equilibrium dissociation constants ranging between 10 Ϫ10 and 10 Ϫ12 M (2) . Unlike nAChR, M␣2-3 does not bind long-chain neurotoxins, a second family of structurally related snake antagonists. Therefore, the main goal of this study was to establish how M␣2-3 specifically and exclusively recognizes short-chain neurotoxins. Additionally, we had previously shown that M␣2-3 partially mimics nAChR (3) . Among the properties shared with nAChR, M␣2-3 induces antinAChR antibodies that block binding of the antagonists to nAChR, and both the antibody and the receptor recognize highly similar topographies on the surface of the antagonist molecules. Therefore, clarification of how a short-chain toxin binds to the antibody may also help to understand how it binds to nAChR.
Determination of the three-dimensional structure of an antibody, free or complexed to its antigen, is presently based on x-ray crystallographic analyses (4, 5) . During the past two decades, the number of crystal structures of antibody fragments has been rising, and to date over 60 structures have been solved. In contrast, the number of elucidated three-dimensional structures of antibody-protein antigen complexes is much lower, perhaps because numerous antigen-antibody complexes are refractory to crystallization, and other approaches may therefore be desirable. In this paper we show that medium resolution three-dimensional structures of an antibody-antigen complex can emerge from the combination of molecular modeling and appropriate mutational experiments.
A number of structural details were available at the beginning of this study. A structural model of the variable fragment of M␣2-3 was known from a homology modeling-based protocol (6) . Residues forming the paratope of the antibody were also known from mutational analyses of its complementarity determining region (CDR) residues (7) . Additionally, the three-dimensional structures of various antigens were known, like those of erabutoxin a (Ea) from Laticauda semifasciata (8) and toxin ␣ from Naja nigricollis (9) . Finally, the residues by which Ea binds to M␣2-3 were identified by mutational analysis (3) and shown to be predominantly located on one of the two faces of the flat toxin. Using these data, the structure of an M␣2-3-toxin complex was studied by docking the toxin epitope onto the antibody paratope (10) . Eight models of antibody-toxin complexes were selected, but the toxin never adopted the same orientation. Therefore, additional information was necessary to render the docking analysis and selection procedure more satisfactory.
In this study, we searched for at least one antibody residue and one antigen residue that may come into proximity upon Ab-Ag complex formation. At first, we used a procedure derived from the double-mutant cycle approach (11) (12) (13) (14) (15) based on inversion of individual charges of the selected residues, and thus evidenced a pairwise interaction or coupling between Asp 31 in the antibody and Arg 33 in the toxin. Using this new experimental information, we proceeded to a new docking analysis of the two interacting surfaces and selected three models compatible with all available experimental data. Furthermore, these models predicted proximity between Lys 47 in the toxin and tyrosines 49 and 50 in the VL domain of the antibody. We therefore performed a second round of double-mutation cycles, which confirmed the validity of the prediction and hence of the models. Two highly similar complex structures consistent with all experimental data were finally selected. A detailed analysis of these structures offers a structural basis for understanding how the antibody specifically and exclusively recognizes shortchain neurotoxins, and plausible information concerning the toxin-binding sites in the nicotinic acetylcholine receptor.
EXPERIMENTAL PROCEDURES
Construction and Site-directed Mutagenesis-M␣2-3 was performed as described previously (1) , and the functional fragments of M␣2-3 were obtained according to Mérienne et al. (7) . The mutants designed for double-cycle mutations were generated using the Muta-Gene M13 in vitro mutagenesis kit from Bio-Rad. The nucleotide probes are: VH D31K (5Ј-TACACCTTCACTAAGTACTATATAAAC-3Ј), VH D31R (5Ј-T-ACACCTTCACTCGCTACTATATAAAC-3Ј), VL Y50K (5Ј-CTGCTGAT-ATACTATGCATCCAGTCGC-3Ј). The mutated codons are underlined. Probes were from Eurobio. The other mutants were produced using the QuickChange site-directed mutagenesis kit from Stratagene. The nucleotide probes used for this mutagenesis methodology are: VL Y49Kcd (5Ј-AAACTGCTGATAAAATATGCATCCAGT-3Ј), VL Y49Kcp (5Ј-ACTGGATGCATATTTTATCAGCAGTTTAG-3Ј). "cd" and "cp" stand for coding and complementary polymerase chain reaction primers. The presence of mutations was checked by automatic sequencing. The Ea mutants K27E, R33E, and K47E were constructed as detailed by Ducancel et al. (3) . The mutant R33D was obtained using the oligonucleotide probes: R33Dcd (5Ј-TGGAGCGATTTCGACGGAACTATA-ATT-3Ј), R33Dcp (5Ј-AATTATAGTACCGTCGAAATCGCTCCA-3Ј).
Production and Characterization of Wild-type and Mutated Proteins-Fused antibody fragments were produced in the periplasm of W3110 bacteria as described previously (7). The periplasmic fractions were then extracted by spheroplast formation, characterized by Western blotting, and standardized by PhoA activity measurement. Ea mutant-ZZ hybrid proteins and the derived toxin mutants were produced and characterized as detailed by Drevet et al. (16) .
Specific Binding Determination-Specific binding of Ea mutants to M␣2-3 was determined by radioimmunoassays as described (3, 17) . Affinities of scFv(M␣2-3)-PhoA mutants for native toxin ␣ or Ea, and relative affinities of double scFv(M␣2-3)-PhoA mutants versus Ea mutants, were determined by enzyme-linked immunosorbent assay as it follows. Microtiter plates were coated overnight at 4°C with 1 g of toxin (Ea) in 100 l of 0.05 M Tris-HCl, pH 7.5. The wells were saturated by adding 200 l of 0.1 M Tris-HCl, pH 7.5, 0.3% bovine serum albumin (overnight, 4°C). Varying amounts of standardized scFv-PhoA fractions (1.5, 0.75, and 0.37 g/ml) were incubated in wells coated with the toxin in 100 l of dilution buffer (0.1 M Tris-HCl, pH 7.5, 0.1% bovine serum albumin), overnight at 4°C. The same amounts of scFv-PhoA were incubated in the presence of excess soluble toxin (5 ϫ 10 Ϫ5 M) to determine nonspecific binding. Toxin/scFv binding was revealed either directly with a colorimetric substrate of PhoA, para-nitrophenyl phosphate, or indirectly using a three-step procedure: (i) incubation with a mouse monoclonal antibody specific for bacterial PhoA (VIAP, Tebu) at 1/10,000 in dilution buffer, (ii) incubation with a peroxidase-conjugated goat anti-mouse antibody (GAM-PO, Immunotech) at 1/5000 in dilution buffer, and finally addition of 2,2Ј-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) colorimetric substrate of peroxidase. In both cases, the detection was made by reading the absorbance at 414 nm. Specific binding was determined by subtracting the nonspecific signal from total binding. For double-mutant binding assays, the specific binding was calculated for each mutated scFv(M␣2-3)-PhoA bound to Ea mutants and compared with the specific binding obtained with the wild-type complex.
Modeling of the Complex between M␣2-3 and Toxin ␣-The threedimensional structure of toxin ␣ used in the docking procedure is a minimized average structure calculated from the eight published solution structures of toxin ␣ (9). Two models of the M␣2-3 variable segment were selected from the four models published by Tenette et al. (6) on the basis of the canonicity of their hypervariable loop structures. Docking of the structure of toxin ␣ onto the structures of the M␣2-3 variable segment was carried out using the program DOCK (18) . This program is based on the positioning algorithm proposed by Wodak and Janin (19) . It optimizes the buried surface area and a low resolution shape complementarity between the two proteins. Both molecules are considered as rigid bodies, and each amino acid is represented by a sphere. In such a low resolution treatment, the backbone geometry is expected to significantly influence the calculations, and side-chain conformation is expected to be less important. The relative position of the two molecules is described by six degrees of freedom: five angles and one distance. At the beginning of the procedure, toxin ␣ was roughly positioned above the combining site of each M␣2-3 model. The 62, 460, 625, and 800,000 structures of the complex were then produced by uniform sampling (with a grid size of 5°) and by using Monte Carlo calculations (18) , respectively. Among these complexes, 6,622 and 1,574 had a buried surface greater than 1200 Å 2 and a satisfactory surface complementarity. They were clustered in 676 and 187 families according to their angular coordinates. We then selected those 863 families consistent with our experimental data. We imposed a maximum distance of 5 Å between the two charges brought by the residues experimentally identified to form an ionic pair. In general, this distance is closer to 3-4 Å (20) . In addition, we imposed on each interacting chain the possibility of moving by 2.5 Å around the average calculated position. Introduction of such flexibility in our calculations mostly resulted from the fact that the antibody conformation was predicted and that the minimized average structure was calculated from the eight published solution structures of antigen (10) . A representative structure of each of the chosen families was finally energy-minimized in a CHARMM22 force field using X-PLOR 3.1 (21) , and visually analyzed using the SYBYL package (TRI-POS inc.).
RESULTS
A total of 44 scFv(M␣2-3) mutants have been prepared to identify the paratope by which M␣2-3 binds to a snake toxin (7) . We have since further refined this surface using 13 new antibody mutations (data not shown). All available data have been gathered in Fig. 1 and Tyr 67 , which belong to the framework regions (FR2L and 3L, respectively), are part of CDRs. This functional area is well delimited since it is surrounded by 15 mutation-insensitive residues. Altogether, the mutated residues defined a homogeneous paratope that has been used in our docking analyses. This region is recognized by an epitope present at the surface of Ea, which includes Space-filling representation of the functional binding site by which M␣2-3 binds to short chain toxins. Indicated in red, orange, and yellow are residues for which at least one mutation lowers the affinity by, respectively, more than 100-fold, 10 -100-fold, and 3-10-fold. Only red and orange residues belong to the interacting surface. Green residues were insensitive to substitutions. VH and VL indicate the heavy and light chains, respectively. Single-letter amino acid codes are used throughout figures.
surrounded by 32 mutation-insensitive residues. We then used further mutational studies combined with docking procedures to investigate how the complementary surfaces of the antibody and antigen interact.
Identification of Pairs of Interacting Residues in the M␣2-3-Toxin
Complex-One to three ionic pairs are often involved in the coupling energy of protein-protein complexes (see Ref. 22 for review). We therefore explored the possibility that the single critical anionic residue Asp 31 in the antibody is in proximity to one of the three critical cationic toxin residues Lys 27 , Arg 33 , and Lys
47
. We used an approach derived from the doublemutant cycle method (11) (12) (13) (14) (15) , by systematically inverting the charge of these four residues, and by evaluating the effects of these single and double mutations by enzyme-linked immunosorbent assay. In other words, we determined the effects of single mutations (one on each partner) versus double-mutant combinations. Additivity of single mutation effects indicates that the two modified residues are not coupled, non-additivity indicating the opposite.
The four toxin variants and the two antibody mutants used in this study were K27E, R33E, R33D, K47E, and D31K or D31R, respectively. The effects of individual or associated mutations were expressed as a percentage of the residual binding capacities (Table I and Fig. 2 ). Each single charge inversion caused a large destabilization of the complex, as expected from residues involved in the protein-protein interface. More precisely, reversal of each positive charge of the toxin and of the negative charge of Asp 31 in the antibody caused an affinity decrease of at least 95% (Table I ). When mutations D31K or D31R in M␣2-3 were combined with either K27E or K47E in the toxin, we observed a further destabilization of the complex, the residual affinity being too low, however, to be accurately estimated. Therefore, concomitant reversal of the charges at position 31 in the antibody and 27 or 47 in the toxin not only did not restore the stability of the complex but induced further destabilization, suggesting that Asp 31 in M␣2-3 is remote from both toxin residues Lys 27 and Lys 47 . In contrast, a substantial restoration of the residual affinity was observed when Ea R33E and Ea R33D were combined with M␣2-3 D31R and M␣2-3 D31K variants. Therefore, once the complex is formed, Arg 33 at the tip of the central loop of the toxin interacts with, or at least is in proximity to, Asp 31 at the surface of CDR1H of M␣2-3. As indicated below, this additional information was exploited in a first round of docking experiments which indicated three compatible models. In these models, Lys 47 in the toxin was predicted to be spatially close to Tyr 49 (FR2L) and/or Tyr 50 (CDR2L), the two most critical functional residues of the antibody light chain. To assess the validity of the prediction, we measured the binding properties of the toxin mutant K47E alone and in combination with the antibody mutants Y49K and Y50K (Table II and Fig. 3 ). We observed that the residual affinity was lower than 5% upon any of the individual mutations, whereas respective recoveries of 13.2% and 9% occurred when K47E/Y49K and K47E/Y50K were combined. No such a recovery was seen when the toxin negative charge was introduced at position 33. Instead, the residual affinity that subsisted upon single mutations of Ea R33D, M␣2-3 Y49K, and M␣2-3 Y50K further decreased when the toxin and antibody mutations were combined. Thus, the recovery in affinity observed above suggests a pairwise interaction or a coupling between Lys 47 in the toxin and Tyr 49 and Tyr 50 in M␣2-3.
Docking Procedures and Refined Analysis of Toxin ␣-M␣2-3
Models-Initial docking experiments were carried out with toxin ␣ (10), which is highly similar to Ea. To compare these docking analyses with ours, we also used toxin ␣ as the docking antigen, inferring from the great similarities (73% sequence identity) between the two toxins that the mutational effects observed with Ea would also be observed with toxin ␣. Five lines of evidence indicate that the two toxins recognize the antibody similarly. First, they bind to it with similar affinities, with respective K d of 10 nM and 35 nM for Ea and toxin ␣ (7). Second, the two toxins have in common 9 (Gln 7 47 , and Ile 50 ) of the 10 residues that constitute the epitope of Ea, the differential residue being Phe 32 in Ea, which is replaced by His 32 in toxin ␣. Third, all common side chains adopt virtually identical conformations and hence nicely superimpose in space (9) . Fourth, chemical modifications of four of these common residues affect the binding of toxin ␣ to the antibody, demonstrating that they belong to the epitope (1). Fifth, NMR experiments revealed that mobility of the amide protons of seven of the common residues is affected when toxin ␣ interacts with the antibody (23), further confirming that the common residues also belong to the epitope of toxin ␣. Thus, a docking procedure of an antibody-toxin complex could equally be performed using either of the two toxins. Using the program DOCK (18), docking calculation generated 863 families of complex models which were screened by imposing three selection criteria. First, at least 8 of the 10 most critical residues of the epitope and 7 (Gly 101 was not considered here) of the 10 most critical residues of the paratope have their side chain 20 -100% more buried in the complex than in the free proteins. Second, the distance between Arg 33 (Nz) in the toxin and Asp 31 (Cz) in M␣2-3 should be lower than 10 Å, which corresponds to a limit energy of interaction between the two opposite charges of at most about 1 kcal/mol (24) . Third, the distance between Lys 27 or Lys 47 in the toxin and Asp 31 in the antibody should be greater than 10 Å. Combination of these criteria resulted in a drastic reduction in the number of docking models, since only seven complexes were still selected. In each of them, the toxin adopts a similar orientation with loops I, II, and III directed toward CDR1H, 3H, and 2L of the paratope, respectively. A representative structure of each of the seven families was energy-minimized in a CHARMM22 force field using X-PLOR 3.1 (Table III) . The correctness of the selected models is suggested by the resulting energy scores. For example, the van der Waals energies were all large and negative (Ϫ45 Ϯ 12 kcal/mol), suggesting the absence of wrong contacts between the antibody and the antigen. In the seven complexes, Asp 31 experimental and calculated data in the six remaining models, i.e. 1-38, 1-112, 2-43, 2-302, 2-346, and 2-613 (Fig. 4) .
The moving amplitudes of the C␣ of the functionally important residues of the toxin relatively to the paratope are shown in Table IV (left part). The greatest moving amplitude of the C␣ of Arg 33 in loop II is only 4.7 Å, whereas it is 8.9 Å and 10.7 Å for Gln 7 and Lys 47 , respectively. Trp 29 occupies a well fixed position on the paratope, with a maximum distance of 3.5 Å within all the models, its indole side chain being a sort of pivot around which the toxin seems to move in all complexes (Fig. 4) . Data in Table IV and Fig. 4 revealed that the models 2-302, 2-43, 1-112, and 1-38 are sufficiently similar to be considered as a single model. The model 2-302 was thus retained because all its paratope residues, including Ala 54 , establish interactions with the toxin. Hence, the three models 2-302, 2-346, and 2-613 were retained.
The three models indicated that the charge of Lys 47 Table I . The color code is the same as in Table I , except for the wild-type complex displayed in yellow. For the latter, the scale is not respected in order to highlight mutation effects. Table II . The color code is the same as in Table I , except for the wild-type complex displayed in yellow. For the latter, the scale is not respected in order to highlight mutation effects.
TABLE II Percentage of residual binding capacity determined by enzyme-linked immunosorbent assay for single and double mutations of Ea and M␣2-3 residues
Color coding is the same as in Table I . VL domain. This prediction received experimental confirmation in a second round of double-mutant cycles, using residues of opposite charges at positions 47 in the toxin and 49 and 50 in the antibody (see above). Therefore, opposite charges at position 47 in the toxin and at positions 49 and 50 in the antibody should be separated by less than 10 Å. This was the case for models 2-302 and 2-346 but not for model 2-613, in which the calculated distance was 12 Å with both Tyr 49 and Tyr 50 (Table  V) . This model was therefore eliminated. Fig. 5 shows how in the two ultimately selected models, 2-302 and 2-346, the toxins are predicted to bind to the paratope. In both models the buried areas are comparable, covering an average surface of about 2000 Å 2 (Table III) . Fig. 6 shows the complementary surfaces of model 2-302 when the two partners are virtually dissociated from each other.
To illustrate further the interaction interfaces predicted by the two models, we calculated the minimal distances between the closest interacting residues and analyzed both the similarities and differences (Table VI) . In both cases, the 10 residues that form the epitope, and all but 1 (Tyr (Ab) were fixed at below 10 Å, and accordingly they vary between 4.2 and 9 Å in the two models. In both models, the residues of the epitope establish comparable types of contacts with the paratope. For example, Gln 7 commonly seems to establish hydrogen bonds with both Tyr 32 
DISCUSSION
This paper proposes two models of an antibody-antigen complex based on the exploitation of single-and double-mutation analyses used in the docking procedure. The strategy involves three major steps, including elucidation of the three-dimensional structures of the antibody and antigen and identification of the residues by which each partner interacts with the other. The third step described in this paper involves both identification of pairs of interacting or coupling residues and docking of the two partners, using all available mutational data.
"Salt Bridge Scanning" to Identify Possible Pairwise Interactions-Initially, double-mutation cycles were successfully developed to identify pairwise interactions between barnase and barstar (12, 13) , scorpion toxins and potassium channels (14, 15) , idiotope and anti-idiotope antibodies (28) , and very recently between ␣-neurotoxins and the nAChR (29) . Additionally, Dall'acqua et al. (30) have used this method to further dissect the interactions of the complex Fv D1.3-HEL, whose structure is known. Generally, the putative residues are substituted by alanine, but in some studies "not-to-alanine" double-mutant cycles might be more suitable in assigning pairwise interactions. This is the case when structural information describing the complex of interest is missing (14) , and/or when a family of ligands appears to exhibit particular and common binding characteristics. Thus, snake toxins bind their natural targets through functional areas rich in cationic residues and of high electrostatic potential (31, 32) . As an illustration, positions ϩ27, ϩ33, and ϩ47 in short-chain neurotoxins are systematically and respectively occupied by a lysine, an arginine, and a lysine, which furthermore are part of overlapping epitopes by which they block the nAChR, or recognize the neutralizing antibody M␣2-3 (3). Suspecting the existence of a stabilizing salt bridge between Asp 31 (M␣2-3) and one of the three toxin cationic side chains cited above, we assessed this possibility by analyzing the effects of double charge inversions. For this purpose, we assumed that irrespectively of the local environment of each interacting partner, the relatively strong nature of the Coulomb forces might influence the stability of the complex, allowing in the case of the double inversion at least partial recovery of the favorable complementarity abolished upon single mutations. The partial but unambiguous binding recovery we noted solely in the case of the combination M␣2-3-D31K or D31R mutants with Ea/R33D or R33E variants strongly suggests that this is indeed the case. The incomplete binding recovery we noted might reflect local structural perturbations affecting the correctness of additional intra-and/or intermolecular stabilizing interactions with adjoining residues (33) . Furthermore, since the upper limit distance for a saltbridge between charged atoms is thought to be approximately 4 Å (20), we predict that a spatial proximity does exist between Arg 33 of the toxin and Asp 31 of the antibody. Owing to the relatively high energy of ionic interactions (neutralization of one of the charged residues of a particular salt-bridge has been estimated as 2.8 kcal/mol) (34), we tentatively exploited this property to identify additional pairwise interactions. For this purpose, we assumed that if two functional residues belonging to the epitope and the paratope, respectively, display side chain distances inferior to 5 Å, then their substitution by favorable cation/anion pairs might introduce enough energy of interaction to define spatial proximity. Our results support this idea, since "scanning" of the interface of Ea-M␣2-3 complex by introducing de novo favorable charge complementarity at different positions led to identification of an unambiguous pairwise interaction between Lys 47 of the toxin moiety and tyrosine residues 49 and 50 of the antibody. This strategy was recently applied in the case of another anti- body-toxin complex, and allowed the spatial analysis of two pairs of interacting residues. 2 We therefore propose the use of the so-called "salt bridge scanning procedure" as an alternative and convenient strategy to map interacting areas, and more precisely to define the spatial environment of any crucial residues meeting the distance criteria cited above within an unknown protein-protein complex.
M␣2-3-Toxin Complexes-Three lines of evidence suggest the validity of our two selected M␣2-3-short-chain toxin models. First, the number of solutions dropped from eight divergent models (10) to two convergent models (average root mean square deviation between the ␣-carbons of the two antigens of 7.0 Ϯ 2.9 Å), when our experimental data were associated with docking experiments. Second, having identified a first series of models using a single pair of proximal residues, we predicted and then experimentally demonstrated the proximity of another pair of interacting residues. Third, in both models, and except for Tyr 67 on the FR3L of the antibody, all residues of the functional epitope and paratope have their side chains buried when the complex is formed. Additionally, the two selected models agree with the general characteristics of an Ab-protein Ag complex, as deduced from crystallographic data. First, the buried surfaces in our models are about 2000 Å 2 , in agreement with the 1200 -2300-Å 2 range seen in crystallographic protein-Ab complexes (35) . Second, we observed a shape complementarity of surfaces with the prominent CDR3H of the paratope, which fits with the concave shape of the epitope. Third, the prediction of one salt bridge agrees with the observation that most Ab-Ag complexes contain between zero and three of these linkages (4, 22) . Fourth, the interacting residues in the antibody involve five tyrosines, in agreement with the observation that an Ab paratope in Ag-Ab complexes usually comprises between three and eight aromatic residues (36) . Fifth, as observed in most other Ab-Ag complexes (35) , the contact area involves a large hydrophobic core, which includes residues Ala 54 , Met 100 , Gly 101 , Ala 102 , Thr
103
, and Leu 106 . Our models, however, suffer from some weaknesses. First, two distinct paratopes emerged from our calculations with inevitable deviations among the observed interactions. For example, Trp 29 interacts with Tyr 32 (Ab) in model 2-346 but not in 2-302. Second, the distances between the same interacting residues differ in the two models. For example, an N-O distance between Gln 7 and Tyr 32 is 3.6 Å and 10 Å in models 2-346 and 2-302, respectively. Third, we did not consider the possibility that a conformational change could have occurred in the antigen and/or antibody upon complex formation (35) . Fourth, since the binding areas defined by mutational analyses are smaller than those from structural data of complexes (35, 37) , some peripheral residues might be missing from the interacting surfaces in our models. Fifth, the packing between the antigen and antibody was weak in the two models. Thus, most distances between interacting elements are rather large, the smallest observed between the interacting side chains being not less than 3 Å, whereas in crystallographic complexes they can approach 0.5-0.7 Å (38). This situation probably results from both the long distance (Ͻ10 Å) imposed in the complex between the pairs of coupled residues and the docking protocol defined for low resolution structures, which tends to preclude nonbonding contacts. The difficulty of accurately predicting the side chain-side chain interaction from the docking calculation was reported recently (39) . Our model therefore needs to be improved. One way forward is to increase the number of experimentally identified contacts and to make some estimation of the associated distances. Ultimately, however, the crystallographic elucidation of the structure of the model will be necessary to validate the resulting models. Nevertheless, we consider that our two models are coherent and precise enough to be analyzed in the context of studies of the particular binding properties of M␣2-3 toward short-chain toxins from snake venoms. 
Basis of Specificity of a nAChR-mimicking Antibody
Fine Specificity of M␣2-3-We have previously shown that M␣2-3 recognized short-chain toxins via a 10-residue epitope located on the concave face of the toxins (3). These residues are spread over the three loops with 47 , and thus might constitute a "common epitope core" through which these toxins establish conservative contacts with M␣2-3. However, and even if M␣2-3 is exclusively specific for short-chain neurotoxins from snakes, variations in its relative affinity (K d ) have been noted in some cases. Thus, while erabutoxins a, b, and c from L. semifasciata venoms, together with toxin ␣ from N. nigricollis, display similar high affinities for M␣2-3, other short-chain neurotoxins are less efficiently recognized. Comparison of the residues forming the site of recognition of M␣2-3 strongly suggests that the weaker the hydrophobic potential of their epitope, the lower their rel- ative affinity for M␣2-3, supporting the idea that the stability of the complex is mostly driven by the entropic term (solvent exclusion (3) . The finding that, at the interface of the complexes, the aromatic rings of tyrosine residues 49 and/or 50 of M␣2-3 are facing the NH3 ϩ group of lysine 47 of the toxin, suggested a noncovalent electrostatic cation-interaction (40, 41) . Interestingly, it has recently been predicted that such a cation-binding site may exist in the ␣-subunit of the nicotinic acetylcholine receptor, establishing contacts with the quaternary group of acetylcholine (42) .
Finally, M␣2-3 does not recognize long-chain toxins, despite the presence of several chemically and structurally common or highly conserved residues between short-and long-chain toxins, including Lys , Glu 38 , and Lys 47 . This suggests that the general three-dimensional architecture of the paratope of M␣2-3 is incompatible with the formation of similar intermolecular contacts between the same residues at the surface of the two structurally related families of curaremimetic toxins. To clarify this situation further, we have undertaken a functional and structural study of another monoclonal antibody exclusively specific for long-chain neurotoxins. 2 How Do Antibody-Toxin and nAChR-Toxin Complexes Compare with Each Other?-The notion of partial mimicry between an antibody and a receptor has been the subject of many studies (43) (44) (45) . The above study, therefore, offers an opportunity to compare how the M␣2-3 and the nicotinic acetylcholine receptor (nAChR) may be recognized by a similar toxin topography. Our data suggest that the flat binding surface offered by the paratope of an antibody might account for the capacity of nAChR to bind to a toxin. This observation is compatible with the recent proposal that the N-terminal domain of a molecule of nAChR, which contains two nonequivalent toxin-binding sites (46) , may share some structural organization with an Ig fold. 3 In this representation, the toxin-binding sites are located on each of the two ␣ subunits of the receptor, especially around the regions 180 -200, with binding contributions from the adjacent ␦ and ␥ subunits. Therefore, the area covered by the toxin on both the antibody and the receptor might correspond to a flat surface of approximately 1000 Å 2 . In addition, the two toxinbinding surfaces appear to involve a number of aromatic residues, with at least Tyr 190 in the receptor (47) and VH Tyr 32 , VH Tyr 52 , VL Tyr 49 , and VL Tyr 50 in the antibody (see Fig. 1) . A more precise comparison as to how Lys 27 and Arg 33 in toxin may interact with the antibody and the receptor can also be made. Indeed, double-cycle mutation analyses revealed how Lys 27 and Arg 33 of another toxin may interact with the murine muscular receptor (29, 48, 49 is predicted to be close to the hydrophobic residues Met 100 and Leu 106 and to the aromatic Tyr 49 . Taken together, these data tend to support the idea that Lys 27 and Arg 33 in short-chain neurotoxins are probably involved in globally comparable binding patterns in both M␣2-3 and nAChR.
